Jennifer L. Lund, PhD is a pharmacoepidemiologist focused on comparative effectiveness research and geriatric oncology. She has expertise in the use of advanced epidemiologic study design and analytic methods to generate robust evidence on the uses, benefits, and harms of therapies that inform decisions made by patients, providers, payers, and policymakers. Her research draws upon data from randomized clinical trials, cancer registries, electronic health records, and insurance claims to study: (1) the delivery of high-quality care and (2) the effectiveness and safety of alternative treatment options. She serves as an Associate Editor for Pharmacoepidemiology and Drug Safety and as editorial board member for the Journal of Geriatric Oncology. She collaborates with multiple other members of the Cancer Outcomes Research Program, including Hanna Sanoff, Katie Reeder-Hayes, Justin Trogdon, Stephanie Wheeler, and Chris Baggett. In her spare time, she enjoys being outside, playing tennis, and trying tasty new NC beers.
Gillings School of Global Public Health, UNC-Chapel Hill